HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

California legislation

This article was originally published in The Rose Sheet

Executive Summary

Phthalates Free Cosmetics Act (AB 908), which would ban the use of di-butyl phthalate and di-(2-ethylhexyl) phthalate in cosmetics and personal care products in California, will be addressed by the Assembly Committee on Health May 3 (1"The Rose Sheet" April 4, 2005, p. 3). Authored by Assembly Member Judy Chu (D-49th), bill is similar to previous legislation introduced by Chu seeking to regulate cosmetic ingredients. Additionally, California Senate Health Committee postpones review of the California Safe Cosmetics Act of 2005 (SB 484), which was scheduled for an April 13 hearing. SB 484, introduced March 30 by Sen. Carol Migden (D-3rd), seeks to regulate the use of chemicals known to cause cancer or reproductive toxicity in cosmetics sold in the state...
Advertisement

Related Content

California Dreaming? Dems Re-Introduce Legislation To Regulate Cosmetics
California Dreaming? Dems Re-Introduce Legislation To Regulate Cosmetics
Advertisement
UsernamePublicRestriction

Register

RS012960

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel